Sanofi U.S. reaches $11.85 million settlement to resolve patient assistance allegations
Topics: SANOFI U.S. SETTLEMENT
As part of the settlement, Sanofi U.S. has also entered into a Corporate Integrity Agreement (CIA) with the Office of the Inspector General of the U.S. Department of Health and Human Services.
Many of the requirements are already incorporated into the company's existing U.S. compliance program.
Sanofi is committed to compliance, and the company's compliance program is regularly enhanced to ensure its controls meet or exceed the complex and evolving legal, regulatory, and industry requirements, as well as the expectations of patients and providers.
This resolution reflects the company's desire to put this investigation behind it and to continue its focus on the needs of patients.
It does not constitute any admission of guilt. ■